Expand RGNX Menu
RGNX MENU

RGNX Stock Summary and Trading Ideas (Regenxbio | NASDAQ:RGNX)

Charts for Today's Stock Price and Implied Volatility in Regenxbio

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for RGNX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Regenxbio (RGNX) Frequently Asked Questions

What does Regenxbio do?

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

What symbol and exchange does Regenxbio stock trade?

Regenxbio trades on the NASDAQ stock market under the symbol RGNX.

What is Regenxbio stock price doing today?

As of May 7, 2024, RGNX stock price climbed to $16.96 with 379,645 million shares trading.

What is Regenxbio's Beta?

RGNX has a beta of 1.73, meaning it tends to be more sensitive to market movements. RGNX has a correlation of 0.14 to the broad based SPY ETF.

How much is Regenxbio worth?

RGNX has a market cap of $831.76 million. This is considered a Small Cap stock.

How much money does Regenxbio make?

Last quarter Regenxbio reported $22 million in Revenue and -$1.43 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.16.

What is the highest and lowest price Regenxbio traded in the last 3 year period?

In the last 3 years, RGNX stock traded as high as $46.46 and as low as $11.83.

What are the top ETFs holding Regenxbio?

The top ETF exchange traded funds that RGNX belongs to (by Net Assets): IJR, VTI, XBI, VB, IWM.

Is Regenxbio (RGNX) a good investment?

RGNX stock has underperformed the market in the last year with a return of -10.2%, while SPY returned +27.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RGNX shares. However, RGNX has outperformed the market in the last 3 month and 2 week periods, returning +30.0% and +8.4%, while SPY returned +5.0% and +3.5%, respectively. This indicates RGNX has been having a stronger performance recently.

What is the support and resistance for Regenxbio (RGNX) stock price?

RGNX support price is $16.21 and resistance is $17.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGNX stock will trade within this expected range on the day.